76 related articles for article (PubMed ID: 23999842)
1. Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.
Huang S; Wang X; Hu C; Ying H
Med Oncol; 2013 Dec; 30(4):710. PubMed ID: 23999842
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic pituitary dysfunction after nasopharyngeal carcinoma irradiation.
Bouzid N; Chamsi A; Barka I; Sghaier S; Tbessi S; Elleuch K; Tebra S
Clin Neurol Neurosurg; 2024 Jan; 236():108100. PubMed ID: 38218060
[TBL] [Abstract][Full Text] [Related]
3. A machine learning approach for predicting radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma undergoing tomotherapy.
Quan KR; Lin WR; Hong JB; Lin YH; Chen KQ; Chen JH; Cheng PJ
Sci Rep; 2024 Apr; 14(1):8436. PubMed ID: 38600141
[TBL] [Abstract][Full Text] [Related]
4. The Hypothalamic Pituitary Thyroid Axis and Sleep.
Shekhar S; Hall JE; Klubo-Gwiezdzinska J
Curr Opin Endocr Metab Res; 2021 Apr; 17():8-14. PubMed ID: 34322645
[TBL] [Abstract][Full Text] [Related]
5. Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Xiang B; Zhu X; He M; Wu W; Pang H; Zhang Z; Yang Y; Li Y; Wang Y; Wang Y; Ye H
Endocr Pract; 2020 Dec; 26(12):1458-1468. PubMed ID: 33471738
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary dysfunction after radiation for brain tumors.
Constine LS; Woolf PD; Cann D; Mick G; McCormick K; Raubertas RF; Rubin P
N Engl J Med; 1993 Jan; 328(2):87-94. PubMed ID: 8416438
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio.
Rooney MK; Andring LM; Corrigan KL; Bernard V; Williamson TD; Fuller CD; Garden AS; Gunn B; Lee A; Moreno AC; Morrison WH; Phan J; Rosenthal DI; Spiotto M; Frank SJ
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686597
[TBL] [Abstract][Full Text] [Related]
8. Thyroid volume changes following adjuvant radiation therapy for breast cancer.
Roberson J; Huang H; Noldner C; Hou W; Mani K; Valentine E; Ryu S; Stessin A
Clin Transl Radiat Oncol; 2023 Mar; 39():100566. PubMed ID: 36582422
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer survivorship consensus statement from the American Head and Neck Society.
Goyal N; Day A; Epstein J; Goodman J; Graboyes E; Jalisi S; Kiess AP; Ku JA; Miller MC; Panwar A; Patel VA; Sacco A; Sandulache V; Williams AM; Deschler D; Farwell DG; Nathan CA; Fakhry C; Agrawal N
Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):70-92. PubMed ID: 35155786
[TBL] [Abstract][Full Text] [Related]
10. Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.
Shen G; Peng Y; Li J; Wu H; Zhang G; Zhao C; Deng X
Front Oncol; 2021; 11():714536. PubMed ID: 34504792
[TBL] [Abstract][Full Text] [Related]
11. Research progress of radiation-induced hypothyroidism in head and neck cancer.
Zhou L; Chen J; Tao CJ; Chen M; Yu ZH; Chen YY
J Cancer; 2021; 12(2):451-459. PubMed ID: 33391441
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors.
McDowell L; Corry J; Ringash J; Rischin D
Front Oncol; 2020; 10():930. PubMed ID: 32596155
[TBL] [Abstract][Full Text] [Related]
13. Thyroid V
Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
[TBL] [Abstract][Full Text] [Related]
14. Pituitary Dysfunction after Radiation for Anterior Skull Base Malignancies: Incidence and Screening.
VanKoevering KK; Sabetsarvestani K; Sullivan SE; Barkan A; Mierzwa M; McKean EL
J Neurol Surg B Skull Base; 2020 Feb; 81(1):75-81. PubMed ID: 32021753
[No Abstract] [Full Text] [Related]
15. Quality evaluation of Panax quinquefolium from different cultivation regions based on their ginsenoside content and radioprotective effects on irradiated mice.
Liao D; Jia C; Sun P; Qi J; Li X
Sci Rep; 2019 Jan; 9(1):1079. PubMed ID: 30705366
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
Xu Y; Shao Z; Tang T; Liu G; Yao Y; Wang J; Zhang L
Oncol Lett; 2018 Nov; 16(5):6126-6132. PubMed ID: 30405757
[TBL] [Abstract][Full Text] [Related]
17. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
18. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
[TBL] [Abstract][Full Text] [Related]
19. Nomogram for radiation-induced hypothyroidism prediction in nasopharyngeal carcinoma after treatment.
Luo R; Li M; Yang Z; Zhan Y; Huang B; Lu J; Xu Z; Lin Z
Br J Radiol; 2017 Feb; 90(1070):20160686. PubMed ID: 27885853
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma with intracranial extension in the era of intensity-modulated radiotherapy: case-control study using propensity score matching method.
Cao CN; Luo JW; Gao L; Xu GZ; Yi JL; Huang XD; Li SY; Xiao JP; Zhang Z
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2209-15. PubMed ID: 26282900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]